STUDY ON THE PREVENTION OF CARDIOVASCULAR EVENTS BY ANTIPLATELET AGENTS AFTER ACUTE CORONARY SYNDROME (AReMIS)

First published 04/03/2014

Last updated 01/02/2017

EU PAS number:

EUPAS5905

Study

Ongoing

Download as PDF

Documents

Study protocol

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Composition of steering group and observers

AReMIS_CS_Contact list_30092013

English (109.15 KB - PDF) View document

STUDY ON THE PREVENTION OF CARDIOVASCULAR EVENTS BY ANTIPLATELET AGENTS AFTER ACUTE CORONARY SYNDROME (AReMIS)

Secondary tabs

Share this page